1. Home
  2. UBX vs APWC Comparison

UBX vs APWC Comparison

Compare UBX & APWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • APWC
  • Stock Information
  • Founded
  • UBX 2009
  • APWC 1996
  • Country
  • UBX United States
  • APWC Taiwan
  • Employees
  • UBX N/A
  • APWC N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • APWC Telecommunications Equipment
  • Sector
  • UBX Health Care
  • APWC Industrials
  • Exchange
  • UBX Nasdaq
  • APWC Nasdaq
  • Market Cap
  • UBX 36.9M
  • APWC 35.3M
  • IPO Year
  • UBX 2018
  • APWC 1997
  • Fundamental
  • Price
  • UBX $1.94
  • APWC $1.57
  • Analyst Decision
  • UBX Strong Buy
  • APWC
  • Analyst Count
  • UBX 2
  • APWC 0
  • Target Price
  • UBX $7.00
  • APWC N/A
  • AVG Volume (30 Days)
  • UBX 203.3K
  • APWC 7.1K
  • Earning Date
  • UBX 04-14-2025
  • APWC 08-26-2024
  • Dividend Yield
  • UBX N/A
  • APWC N/A
  • EPS Growth
  • UBX N/A
  • APWC N/A
  • EPS
  • UBX N/A
  • APWC 0.18
  • Revenue
  • UBX N/A
  • APWC $468,125,000.00
  • Revenue This Year
  • UBX N/A
  • APWC N/A
  • Revenue Next Year
  • UBX $33.62
  • APWC N/A
  • P/E Ratio
  • UBX N/A
  • APWC $8.84
  • Revenue Growth
  • UBX N/A
  • APWC 12.16
  • 52 Week Low
  • UBX $0.94
  • APWC $1.20
  • 52 Week High
  • UBX $3.10
  • APWC $2.02
  • Technical
  • Relative Strength Index (RSI)
  • UBX 48.69
  • APWC 48.26
  • Support Level
  • UBX $1.99
  • APWC $1.59
  • Resistance Level
  • UBX $2.17
  • APWC $1.81
  • Average True Range (ATR)
  • UBX 0.22
  • APWC 0.11
  • MACD
  • UBX -0.05
  • APWC -0.00
  • Stochastic Oscillator
  • UBX 22.41
  • APWC 23.17

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)

Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in owning operating companies engaged in the power cable, telecommunication cable, enameled wire, and electronic cable industry. It also provides project engineering services to customers. Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and Rest of the World.

Share on Social Networks: